These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24662263)

  • 1. Niacin activates the G protein estrogen receptor (GPER)-mediated signalling.
    Santolla MF; De Francesco EM; Lappano R; Rosano C; Abonante S; Maggiolini M
    Cell Signal; 2014 Jul; 26(7):1466-75. PubMed ID: 24662263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
    Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
    Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
    Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
    Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
    Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
    Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
    Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
    Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
    Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
    J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
    Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM
    Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
    Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
    Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells.
    Bartella V; De Francesco EM; Perri MG; Curcio R; Dolce V; Maggiolini M; Vivacqua A
    Cell Signal; 2016 Feb; 28(2):61-71. PubMed ID: 26607335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
    De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
    Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs).
    Pupo M; Vivacqua A; Perrotta I; Pisano A; Aquila S; Abonante S; Gasperi-Campani A; Pezzi V; Maggiolini M
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):23-32. PubMed ID: 23748028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells.
    Pupo M; Bodmer A; Berto M; Maggiolini M; Dietrich PY; Picard D
    Oncotarget; 2017 Jul; 8(29):46728-46744. PubMed ID: 28596490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner.
    Ren J; Guo H; Wu H; Tian T; Dong D; Zhang Y; Sui Y; Zhang Y; Zhao D; Wang S; Li Z; Zhang X; Liu R; Qian J; Wei H; Jiang W; Liu Y; Li Y
    Oncol Rep; 2015 Apr; 33(4):1929-37. PubMed ID: 25647524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.